De-Risking Product Decisions in MedTech Startups with Brent Lavin of Ironwood MedTech Partners

Product decisions made during early development determine commercialization outcomes years later. Wrong choices about regulatory pathways, feature sets, and market segments create compounding problems limiting commercial success.Christian Espinosa and Trevor Slattery explore product management with Brent Lavin, Chief Product Catalyst of Ironwood MedTech Partners, covering why 510(k) pathways average four years while PMA programs require seven to nine years, and how feature set alignment shapes success.The engineering mindset applies hypothesis testing to product development through iterative refinement.Practical for MedTech founders and product teams.Episode Breakdown:00:02 Introduction04:35 Ironwood origin06:02 De-risking decisions10:15 Hypothesis testing14:30 Pathway selection18:45 Timelines22:20 Claims limits26:40 Feature alignment30:15 Segmentation34:55 Clinical trials38:45 Entrepreneurship40:45 Insights43:29 CloseThe Med Device Cyber Podcast is brought to you by Blue Goat Cyber, cybersecurity experts providing essential security solutions for the medical device industry. Learn more by visiting https://bluegoatcyber.com.If you're interested in our services or partnering with us, schedule a Discovery Session: https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-sessionChristian Espinosa is the CEO and founder of Blue Goat Cyber. Trevor Slattery is the Chief Operating Officer at Blue Goat Cyber.Christian Espinosa on LinkedIn: https://www.linkedin.com/in/christianespinosa/Trevor Slattery on LinkedIn: https://www.linkedin.com/in/trevor-slattery-34852b1a9Blue Goat Cyber on LinkedIn: https://www.linkedin.com/company/blue-goat-cyber/Blue Goat Cyber on Instagram: https://www.instagram.com/bluegoatcyber/Blue Goat Cyber on Facebook: https://www.facebook.com/bluegoatcyber/Blue Goat Cyber on YouTube: https://www.youtube.com/@BlueGoatCyber/?sub_confirmation=1